Search

Author/Creator Tada, Keisuke

2. Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study. Issue 12 (15th October 2020)

Authors:
Sunami, Kazutaka; Suzuki, Kenshi; Ri, Masaki; Matsumoto, Morio; Shimazaki, Chihiro; Asaoku, Hideki; Shibayama, Hirohiko; Ishizawa, Kenichi; Takamatsu, Hiroyuki; Ikeda, Takashi; Maruyama, Dai; Kaneko, Hitomi; Uchiyama, Michihiro; Kiguchi, Toru; Iyama, Satoshi; Murakami, Hirokazu; Takahashi, Keishi...
Journal:
Cancer science
Issue:
Volume 111:Issue 12(2020)
Page Start:
4526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. (8th September 2022)

Authors:
Ishida, Tadao; Ito, Shigeki; Tanaka, Junji; Uchiyama, Michihiro; Kawano, Yawara; Moreau, Philippe; Martin, Thomas; Risse, Marie-Laure; Tada, Keisuke; Suzuki, Kenshi; Ishizawa, Kenichi
Journal:
Japanese journal of clinical oncology
Issue:
Volume 52:Number 12(2022)
Page Start:
1446
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗